Fulgent Genetics, Inc. (FLGT) Ownership
FLGT ownership summary
as of October 18, 2026- Institutions
- 58.2% of shares outstanding
- Insiders
- 37.75% of shares outstanding
- Shares outstanding
- 27.5M
- Float
- 16.7M shares available to trade
- Short interest
- 13.06% 2.2M shares short
- Days to cover
- 6.68 short interest down 3.4% vs prior month
- Institutions 58.18%
- Insiders 37.75%
- Other investors 4.08%
FLGT top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 8.31% | 2.3M | $45.3M | −487,850 (−17.6%) | June 30, 2026 |
| 2 | Acadian Asset Management LLC | 3.70% | 1.0M | $20.2M | −216,038 (−17.5%) | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 2.87% | 789K | $15.6M | −90,652 (−10.3%) | June 30, 2026 |
| 4 | Jacobs Levy Equity Management, Inc. | 2.84% | 782K | $15.5M | +425,757 (+119.5%) | June 30, 2026 |
| 5 | JPMorgan Chase & Co | 2.75% | 757K | $15.0M | +296,195 (+64.3%) | June 30, 2026 |
| 6 | Diametric Capital, LP | 2.54% | 698K | $13.8M | +336,738 (+93.3%) | June 30, 2026 |
| 7 | Ameriprise Financial Inc | 2.44% | 670K | $13.3M | +106,709 (+18.9%) | June 30, 2026 |
| 8 | Dimensional Fund Advisors, Inc. | 2.27% | 625K | $12.4M | −46,309 (−6.9%) | June 30, 2026 |
| 9 | Geode Capital Management, LLC | 1.89% | 521K | $10.3M | −63,193 (−10.8%) | June 30, 2026 |
| 10 | State Street Corp | 1.81% | 499K | $9.9M | −30,726 (−5.8%) | June 30, 2026 |
| 11 | Invenomic Capital Management, LP | 1.81% | 498K | $9.9M | −112,031 (−18.4%) | June 30, 2026 |
| 12 | Two Sigma Investments LLC | 1.46% | 401K | $7.9M | +78,797 (+24.5%) | June 30, 2026 |
| 13 | Charles Schwab Investment Management Inc | 1.28% | 351K | $7.0M | −3,197 (−0.9%) | June 30, 2026 |
| 14 | Millennium Management LLC | 1.17% | 321K | $6.4M | −80,909 (−20.1%) | June 30, 2026 |
| 15 | The Goldman Sachs Group Inc | 1.12% | 308K | $6.1M | −3,483 (−1.1%) | June 30, 2026 |
| 16 | D. E. Shaw & Co LP | 1.06% | 292K | $5.8M | −194,764 (−40.0%) | June 30, 2026 |
| 17 | HRT FINANCIAL LLC | 0.83% | 229K | $4.5M | +182,996 (+394.0%) | June 30, 2026 |
| 18 | Peapod Lane Capital LLC | 0.81% | 224K | $4.4M | +3,580 (+1.6%) | June 30, 2026 |
| 19 | Point72 Asset Management, L.P. | 0.77% | 212K | $4.2M | +211,708 (0.0%) | June 30, 2026 |
| 20 | Medina Singh Partners, LLC | 0.70% | 193K | $3.8M | +22,992 (+13.5%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 9 holders added 1.7M shares and 11 cut 1.3M.
FLGT top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.01% | 552K | $10.9M | — | August 31, 2026 |
| 2 | iShares Russell 2000 ETF | 1.69% | 464K | $9.2M | −5,376 (−1.1%) | September 30, 2026 |
| 3 | Columbia Small Cap Value Discv A | 1.45% | 399K | $7.9M | +2,500 (+0.6%) | August 31, 2026 |
| 4 | Xtrackers MSCI World Swap ETF 1C | 1.10% | 303K | $6.0M | −1,906 (−0.6%) | December 31, 2025 |
| 5 | BlackRock Advantage Small Cap Core Instl | 1.09% | 301K | $6.0M | −5,146 (−1.7%) | August 31, 2026 |
| 6 | Invenomic Institutional | 0.96% | 263K | $5.2M | −201,293 (−43.4%) | July 31, 2026 |
| 7 | Fidelity Small Cap Index | 0.77% | 213K | $4.2M | +2,415 (+1.1%) | July 31, 2026 |
| 8 | iShares Russell 2000 Value ETF | 0.61% | 168K | $3.3M | +254 (+0.2%) | September 30, 2026 |
| 9 | Schwab Fundamental U.S. Small CompanyETF | 0.51% | 141K | $2.8M | +196 (+0.1%) | September 30, 2026 |
| 10 | iShares Biotechnology ETF | 0.50% | 137K | $2.7M | −1,040 (−0.8%) | September 30, 2026 |
| 11 | DFA US Small Cap I | 0.45% | 123K | $2.4M | — | August 31, 2026 |
| 12 | Fidelity Extended Market Index | 0.39% | 106K | $2.1M | −2,019 (−1.9%) | August 31, 2026 |
| 13 | Vanguard Russell 2000 ETF | 0.38% | 104K | $2.1M | −7,154 (−6.4%) | September 30, 2026 |
| 14 | DFA US Micro Cap I | 0.37% | 103K | $2.0M | +62 (+0.1%) | August 31, 2026 |
| 15 | PIMCO RAE US Small Instl | 0.36% | 100K | $2.0M | −24,723 (−19.9%) | June 30, 2026 |
| 16 | Schwab US Small-Cap ETF™ | 0.32% | 88K | $1.8M | +54 (+0.1%) | September 30, 2026 |
| 17 | Multi-Manager Small Cap Eq Strat Inst | 0.31% | 85K | $1.7M | −9,461 (−10.1%) | September 30, 2026 |
| 18 | Stt Strt® SPDR® S&P®HlthCrSvcsETF | 0.30% | 83K | $1.6M | −2,500 (−2.9%) | September 30, 2026 |
| 19 | Xtrackers S&P 500 Swap ETF 1C | 0.29% | 79K | $1.6M | −50,326 (−38.8%) | December 31, 2025 |
| 20 | Dimensional US Small Cap ETF | 0.29% | 79K | $1.6M | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
FLGT insider transactions
latest 15| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-02 | Hanlin Gao | Sell | $28.33 | 1,075 | $30,455 |
| 2025-12-02 | Jian Xie | Sell | $28.33 | 1,140 | $32,296 |
| 2025-11-28 | Hanlin Gao | Sell | $29.57 | 943 | $27,885 |
| 2025-11-28 | Jian Xie | Sell | $29.57 | 1,198 | $35,425 |
| 2025-11-24 | Hanlin Gao | Sell | $30.47 | 535 | $16,301 |
| 2025-11-24 | Jian Xie | Sell | $30.47 | 681 | $20,750 |
| 2025-11-19 | Jian Xie | Sell | $29.10 | 10,000 | $291,000 |
| 2025-09-03 | Hanlin Gao | Sell | $22.03 | 1,063 | $23,418 |
| 2025-09-03 | Jian Xie | Sell | $22.03 | 1,128 | $24,850 |
| 2025-08-27 | Hanlin Gao | Sell | $21.48 | 943 | $20,256 |
| 2025-08-27 | Jian Xie | Sell | $21.48 | 1,199 | $25,755 |
| 2025-08-25 | Hanlin Gao | Sell | $21.50 | 548 | $11,782 |
| 2025-08-25 | Jian Xie | Sell | $21.50 | 696 | $14,964 |
| 2025-05-27 | Hanlin Gao | Sell | $20.54 | 1,039 | $21,341 |
| 2025-05-27 | Jian Xie | Sell | $20.54 | 1,873 | $38,471 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
FLGT shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns FLGT
Institutional investors own 58.2% of Fulgent Genetics's shares and insiders 37.75%. The largest holder is BlackRock Inc with 8.31% of the shares (2.3M), as of June 30, 2026. Among the top 20 institutions, 9 added shares and 11 reduced their stake in the latest filings. Short interest is 13.06% of the float, or 6.68 days of average trading volume. The share count rose 141.0% since 2015.
Related: FLGT analyst forecast, FLGT key metrics. See the FLGT stock overview for the latest quote and news.
FLGT ownership FAQ
Who owns the most Fulgent Genetics stock?
The largest shareholders of Fulgent Genetics are BlackRock Inc (8.31%), Acadian Asset Management LLC (3.70%), Vanguard Capital Management, LLC (2.87%), Jacobs Levy Equity Management, Inc. (2.84%), JPMorgan Chase & Co (2.75%).
What percentage of Fulgent Genetics is owned by institutions?
Institutions hold 58.2% of Fulgent Genetics's shares outstanding; insiders hold 37.75%.
Which funds own Fulgent Genetics?
The largest fund holders of Fulgent Genetics are Vanguard MStar Total Stk Mkt Idx Invest (2.01%), iShares Russell 2000 ETF (1.69%), Columbia Small Cap Value Discv A (1.45%), Xtrackers MSCI World Swap ETF 1C (1.10%), BlackRock Advantage Small Cap Core Instl (1.09%).
What is Fulgent Genetics's short interest?
2.2M shares of Fulgent Genetics were sold short, 13.06% of the float; at the average daily volume it would take 6.68 days to cover.
Are insiders buying or selling Fulgent Genetics?
Of the latest 15 reported insider transactions in Fulgent Genetics (since May 27, 2025), 0 were purchases and 15 were sales.
How many shares of Fulgent Genetics are outstanding?
Fulgent Genetics has 27.5M shares outstanding, of which 16.7M are in the public float.